4//SEC Filing
RUBIN PAUL D 4
Accession 0001210905-25-000006
CIK 0001709941other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 4:21 PM ET
Size
8.8 KB
Accession
0001210905-25-000006
Insider Transaction Report
Form 4
RUBIN PAUL D
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-09$6.57/sh+18,000$118,260→ 18,000 total - Sale
Common Stock
2025-12-09$12.00/sh−18,000$216,000→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-09−18,000→ 9,383 totalExercise: $6.57Exp: 2032-05-28→ Common Stock (18,000 underlying)
Footnotes (2)
- [F1]The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024.
- [F2]The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
Documents
Issuer
BioAge Labs, Inc.
CIK 0001709941
Entity typeother
Related Parties
1- filerCIK 0001210905
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 4:21 PM ET
- Size
- 8.8 KB